One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease-Reference-Cited by-同舟云学术

One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease

Published:2024-08 Issue: Volume:225 Page:25-34
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Mankerious Nader,Toelg Ralph,Vogel Birgit,Sartori Samantha,Angiolillo Dominick J.,Vranckx Pascal,Feng Yihan,de la Torre Hernandez Jose M.,Krucoff Mitchell W.,Bhatt Deepak L.,Spirito Alessandro,Cao Davide,Chehab Bassem M.,Kunadian Vijay,Maksoud Aziz,Picon Hector,Sardella Gennaro,Thiele Holger,Varenne Olivier,Windecker Stephan,Richardt Gert,Valgimigli Marco,Mehran Roxana^ORCID

Publisher

Elsevier BV

Reference29 articles.

1. Trial design principles for patients at high bleeding risk undergoing PCI: JACC scientific expert panel;Capodanno;J Am Coll Cardiol,2020

2. Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents;Koppara;Circ Cardiovasc Interv,2015

3. XIENCE 90 and XIENCE 28 Investigators. 3- or 1-month DAPT in patients at high bleeding risk undergoing everolimus-eluting stent implantation;Mehran;JACC Cardiovasc Interv,2021

4. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Lawton;J Am Coll Cardiol,2022

5. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease;Valgimigli;Eur Heart J Cardiovasc Pharmacother,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double Trouble: Dual Antiplatelet Therapy Duration Dilemma in Chronic Kidney Disease Patients With High Bleeding Risk;The American Journal of Cardiology;2024-09